Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × fosbretabulin × Clear all

NCT03014297 2019-08-08

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Phase 1 Terminated

Neuroendocrine Tumors